There is a new medication for treating hepatitis C.
Last week, the Food and Drug Administration approved the use of a new drug for treating all forms of hepatitis C in eight weeks, improving treatment options for patients with the disease.
Dr. Arthur Yan of Core Gastroenterology in Exeter said it’s a great new treatment option, and it also serves as a reminder that the Centers for Disease Control recommends that all baby boomers be tested for the disease.
“It can lie dormant for 20-30 years, but untreated can result in cirrhosis of the liver,” said Yan. “Many people are not even aware they have it. Some people are beginning to present with cirrhosis.”
People in the baby boomer age range should particularly seek testing if they lived their early life with certain risks, including drug or alcohol use. Hepatitis can also be transmitted through sexual activity.
Hepatitis C is a viral disease that causes inflammation of the liver that can lead to diminished liver function or liver failure. According to the Centers for Disease Control and Prevention, an estimated 2.7 million to 3.9 million people in the United States have chronic HCV.
Read full article: FDA approves new drug to treat hepatitis C
|Read Full Article: FDA approves new drug to treat hepatitis C|